The Ergomed team will attend the World Orphan Drug Congress USA 2023 in Washington, DC, May 23-25
The World Orphan Drug Congress brings together leading pharmaceutical and biotech companies, government and regulatory authorities, patient advocacy groups, payers, investors and solution providers. The conference is a place to meet and brainstorm ways to advance orphan drug development and improve access to life-saving therapies.
This year’s focus is on breaking down silos and fostering collaboration to help rare disease patients
To meet with our Business Development team, please fill out the form below to schdule a meeting.
Scott Treiber
Executive Vice President, Strategic Development
scott.treiber@ergomedplc.com
Kailyn Bell
Senior Director, Business Development
kailyn.bell@ergomedplc.com
Jane McNiff
Senior Director, Business Development
jane.mcniff@ergomedplc.com
